Neuberger Berman Group
HCAT icon

Neuberger Berman Group’s Health Catalyst HCAT Stock Holding History

Neuberger Berman Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Buy
+18,069
New +$26.1K ﹤0.01% 2307

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group's HCAT Position: Q2 2026 in Review

Neuberger Berman Group opened a new position in Health Catalyst (HCAT) in Q2 2026: 18,069 shares worth $36K. The stake represents ﹤0.01% of the portfolio and ranks #2307 among its holdings.

127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Neuberger Berman Group held 18,069 shares of Health Catalyst worth $36K as of Q2 2026.
  • Health Catalyst was a new Neuberger Berman Group position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2307 holding.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.